Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
about
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Global N-acetylaspartate declines even in benign multiple sclerosisCytokines as Biomarkers of Treatment Response to IFN β in Relapsing-Remitting Multiple SclerosisBenign multiple sclerosis: does it exist?Estimating typical multiple sclerosis disability progression speed from clinical observations.Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.Quantitative T2' imaging in patients with clinically isolated syndromeVisual pathway axonal loss in benign multiple sclerosis: a longitudinal study.Disability in multiple sclerosis: a reference for patients and clinicians.Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease durationGender issues in multiple sclerosis: an update.Benign multiple sclerosis: aspects of cognition and neuroimaging.Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.Benign multiple sclerosis in Crete.Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis.Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.Characterising aggressive multiple sclerosis.A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.Induction therapy for the management of early relapsing forms of multiple sclerosis. A critical opinion.Benign multiple sclerosis: a new definition of this entity is needed.Patient reported outcomes in benign multiple sclerosis.Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.Cognitive impairment after three decades of multiple sclerosis.
P2860
Q30712257-5FBF8CEC-AA2B-471E-91B2-9FA24547CC04Q33725131-9D23EB6F-0F02-42C3-BE74-93CB28694540Q34053077-1DA5A4DC-4CC4-4BA9-AD54-E0D41C7E4DFBQ34640135-E9DDFA48-7405-4A49-B000-43C1C8C3AEAFQ35348224-156F436D-B895-45C2-A8E5-6DA2C35D15EEQ35629319-4D789298-A183-451A-88AE-07CCE894584AQ35938583-73E7D23D-B6AB-44E0-9F2B-7E785D73918FQ35980966-1FCBF2E8-9E70-4581-8385-F45541A0FB74Q36190102-0F1A3E3A-7B24-4E62-BBC5-85100090B391Q36841485-5EB34C06-D47F-4CDB-B9B1-3B5212FC5AA5Q37303007-2C3463BD-5EAC-4E7E-BEFB-197B943512E3Q37813691-AD8761F7-E446-4742-82A3-4E8DBC2AF246Q38704455-4D43F735-459C-4AE2-B5A6-587C85C83693Q39436503-102A2A6F-9ABB-4CC0-8E1D-DF955274E10EQ42653149-B47587D9-CC39-425A-97E8-005FA8CF37DEQ43223354-BD47F1C7-9D5C-4D70-804B-4BCD7DC2362DQ44130617-CA858EF1-8ECF-4310-89F2-8AC5A7C69D9AQ44500292-A6AA8980-3884-477E-B5E5-7E70C2274743Q45145307-F9383112-DCCA-4458-AD3F-7ED856338C7EQ47244682-321504AB-970C-4C0A-A78D-C6A05E179D38Q47307744-55F15B75-E347-4702-94C5-CA758C79A038Q47791142-0F6FE78D-77F9-4DFB-916E-EF87D43764C7Q47926720-068A4571-B5B4-423B-ABCA-E99FA9901627Q48605793-268DBC78-73FE-4176-81DE-BADF4CABD022Q48898396-5D156684-9ED7-4304-B8F7-38FDB26C982EQ50551208-224D05D7-990B-4A4A-86FD-04A630234462Q51887984-FAEAA5D1-6932-426F-81BA-450434C0ED78
P2860
Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Long-term clinical relevance o ...... ign after 10 years of disease.
@en
Long-term clinical relevance o ...... ign after 10 years of disease.
@nl
type
label
Long-term clinical relevance o ...... ign after 10 years of disease.
@en
Long-term clinical relevance o ...... ign after 10 years of disease.
@nl
prefLabel
Long-term clinical relevance o ...... ign after 10 years of disease.
@en
Long-term clinical relevance o ...... ign after 10 years of disease.
@nl
P50
P356
P1476
Long-term clinical relevance o ...... ign after 10 years of disease.
@en
P2093
L Costelloe
P304
P356
10.1136/JNNP.2008.143586
P407
P577
2008-05-13T00:00:00Z